[Skip to content]

European Parkinson's Disease Association
Search our Site

EPNN Journal Issue 10 - Summer 2007

Next issue
Previous Issue
EPNN Journal issue 10
Click on image to download


  • Blood Test for Parkinson’s
    Australian scientists have developed a new blood test that they believe will be able to diagnose and monitor treatment of Parkinson’s disease. The test measures a particular protein, alpha-synuclein, which occurs in low levels in the brains of people with Parkinson’s.

  • Medicalise Me: Experts Look at Perceptions of Illness

  • Pesticides Risk Highlighted

    New findings on the role of environmental factors in Parkinson’s disease development were presented at a recent meeting of the Collaborative Centers for Parkinson’s Disease Environmental Research (CCPDER).

  • The Narcolepsy Connection

    Parkinson’s shares some symptoms with narcolepsy, a sleep condition characterised by sudden and uncontrollable episodes of deep sleep, fatigue and other sleep disorders. A report by University of California, Los Angeles (UCLA), published in the May issue of Brain, suggests that people with Parkinson’s have severe damage to the same small groups of neurons whose loss causes narcolepsy.

  • Free Prescriptions for Wales

    On 1 April 2007, Wales became the first country in the UK to abolish prescription charges. This is good news for younger people with Parkinson’s living there, as they will no longer have to pay for their Parkinson’s medication.

  • Betting Websites Increase Chance of Addiction

    People with Parkinson’s could be adversely affected by the growth of online betting because they are more likely to become gambling addicts, according to a recent editorial, published in the British Medical Journal.

  • Exercise May Offer Parkinson’s Protection

    The risk of developing Parkinson’s may be reduced with moderate to vigorous exercise, according to research recently presented at the American Academy of Neurology’s 59th Annual Meeting.

  • New Creatine Research Study

    The NIH National Institute of Neurological Disorders and Stroke (NINDS) is launching a large-scale clinical trial in the US to investigate whether the nutritional supplement creatine can slow Parkinson’s progression.

  • Dopamine-related Drugs Affect Reward-seeking Behaviour

    Drugs that adjust dopamine levels in the brain greatly affect how people react to success and failure, according to research that has been presented at the American Academy of Neurology’s 59th Annual Meeting held in Boston at the end of April.

  • Treatment Strategy Debated in Naples

    The Holiday Inn in Castel Volturno, just outside Naples, Italy, was the setting for Solvay’s second International Forum on Advanced Parkinson’s Disease, in May.

  • Gene Therapy Trial Provides Promising Results

    The results of an encouraging gene therapy open label trial, were published in The Lancet in June.

  • PDNS Core Competencies - Literature Review

    Janet Doherty and Orna Moore examine the PDNS’s role from its inception in 1989 to the present day

  • The Sadness Behind the Mask

    Slovenian Zvezdan Pirtošek explores the complexities of depression

  • An Accidental Artist

    Kathleen Reardon reveals the transforming effect that painting has had on her life

  • Cognition and Behaviour

    Carlo Colosimo and Dorina Tiple explore some of the brain's complexities

  • Quality of Life and Age at Disease Onset

    Maja Relja talks about symptoms, treatment, and the impact on young onset Parkinsonians

  • Managing Stress

    Nutritional Therapist Lucille Leader explores the biochemical nature of stress and a management protocol developed in her PD clinic.